Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data.

ABSTRACT:

Aims

There has been a dramatic increase in hypoglycaemic agent expenditure. We assessed the variability in prescribing costs at the practice level and the relationship between expenditure and the proportion of patients achieving target glycaemic control.

Methods

We utilized national prescribing data from 406 general practices in Wales. This was compared against glycaemic control (percentage of patients achieving a HbA1c level < 59 mmol/mol in the preceding 12 months). Analyses were adjusted for the number of patients with diabetes in each general practice and the Welsh Index of Multiple Deprivation.

Results

There was considerable heterogeneity in hypoglycaemic agent spend per patient with diabetes, Median = £289 (IQR 247-343) range £31.1-£1713. Higher total expenditur

SUBMITTER: Taylor PN 

PROVIDER: S-EPMC9545615 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature